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Abstract
Background: The dopamine transporter (DAT) plays a critical role in regulating dopamine
neurotransmission. Variations in DAT or changes in basal dopaminergic tone have been shown to
alter behavior and drug responses. DAT is one of the three known high affinity targets for cocaine,
a powerful psychostimulant that produces reward and stimulates locomotor activity in humans and
animals. We have shown that cocaine no longer produces reward in knock-in mice with a cocaine
insensitive mutant DAT (DAT-CI), suggesting that cocaine inhibition of DAT is critical for its
rewarding effect. However, in DAT-CI mice, the mutant DAT has significantly reduced uptake
activity resulting in elevated basal dopaminergic tone, which might cause adaptive changes that alter
responses to cocaine. Therefore, the objective of this study is to determine how elevated
dopaminergic tone affects how mice respond to cocaine.
Results: We examined the cocaine induced behavior of DAT knockdown mice that have DAT
expression reduced by 90% when compared to the wild type mice. Despite a dramatic reduction
of DAT expression and marked elevation in basal dopamine tone, cocaine produced reward, as
measured by conditioned place preference, and stimulated locomotor activity in these mice.
Conclusion: A reduction in DAT expression and elevation of dopaminergic tone do not lead to
adaptive changes that abolish the rewarding and stimulating effects of cocaine. Therefore, the lack
of reward to cocaine observed in DAT-CI mice is unlikely to have resulted from the reduced DAT
activity but instead is likely due to the inability of cocaine to block the mutated DAT and increase
extracellular dopamine. This study supports the conclusion that the blockade of DAT is required
for cocaine reward and locomotor stimulation.
Background
Cocaine is a powerful psychostimulant and an addictive
drug of abuse. Considerable evidence indicates that the
blockade of the dopamine transporter (DAT) by cocaine
and the subsequent elevation of extracellular dopamine
(DA) primarily mediate the stimulating and rewarding
effects of cocaine [1-4]. DA is an important neurotrans-
mitter involved in many critical functions including
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reward [5]. The DA transporter is responsible for DA
reuptake and recycling, and thus plays a critical role in
maintaining DA homeostasis and in regulating DA neuro-
transmission. Variations or polymorphisms in the DAT
gene have been associated with behavioral changes and
modified drug response. For instance, it has been shown
that the 9-repeat allele of a 3' variable number tandem
repeat polymorphism in the DAT gene is associated with
lower basal DA tone and greater DA release in response to
nicotine [6]. More significantly, the 9-repeat allele has
also been associated with attention deficit/hyperactivity
disorder and increased aggression [7,8].
There is also evidence that changes to DAT in animals can
affect their drug responses and behavior. It is widely
believed that the addictive psychostimulants elevate loco-
motor activity and produce reward by activating the
dopaminergic system. However, cocaine still produces
reward in dopamine transporter knockout mice (DAT-KO
mice) [9-11]. Importantly, DAT-KO mice show additional
differences from wild type mice. The selective serotonin
transporter (SERT) inhibitor fluoxetine and the selective
norepinephrine transporter (NET) inhibitor nisoxetine do
not produce reward in wild type mice, but both drugs pro-
duce reward in DAT-KO mice [12-14]. Fluoxetine and
reboxetine (another NET selective inhibitor) have also
been reported to increase extracellular DA levels in the
nucleus accumbens in DAT-KO mice, but not in wild type
mice [13,15,16]. It is likely that the absence of DAT in
DAT-KO mice has altered neuronal signaling pathways.
Therefore, it is not clear how the modulation of DAT
would affect cocaine induced reward and locomotor activ-
ity.
To avoid the adaptive changes seen in DAT-KO mice, we
previously generated a knock-in mouse line with a
cocaine-insensitive DAT (DAT-CI) [17]. In DAT-CI mice,
cocaine decreases locomotor activity and does not pro-
duce reward as measured by conditioned place preference
(CPP) [17]. Our results suggest that the blockade of DAT
is required for cocaine induced reward and locomotor
stimulation. In DAT-CI mice however, the modified DAT
has reduced transport function resulting in elevated extra-
cellular DA levels and hyperactivity. Therefore, it is a con-
cern that cocaine's inability to produce reward or to
increase locomotor activity might be due to increased DA
basal tone or other adaptations caused by the reduced DA
transport function in DAT-CI mice.
A DAT knock-down mouse line (DAT-KD) has been gen-
erated which has a 90% reduction in DAT expression
compared to the wild type mice [18]. DAT-KD mice dis-
play significantly altered behaviors, such as hyperactivity
and slower habituation to a novel environment. Impor-
tantly, amphetamine, which increases locomotion in wild
type mice, reduces locomotor activity in DAT-KD mice
[18]. DAT-KD mice also exhibit differences from wild type
mice in their response to sweet rewards [19,20]. These
studies indicate that alterations in DAT expression can
change an animal's behavior and modify its response to
drugs including psychostimulants. DAT-KD mice provide
a good animal model to test how reduced DAT expression
affects cocaine-induced animal behaviors.
In the current study, we compared the cocaine response in
DAT-KD mice and wild type mice with two behavioral
tests: drug induced locomotion and CPP. Our results
revealed the effects of reduced DAT expression on cocaine-
elicited animal behaviors.
Results
Locomotion stimulation
First, we examined the effects of cocaine or saline injec-
tion on mouse locomotor activity. WT and DAT-KD mice
were placed in an open field box (25 cm × 25 cm) and
locomotor activity was recorded for 60 minutes. After the
habituation period, cocaine or saline were injected and
mouse locomotor activities were monitored for another
60 minutes. Figure 1A and 1B show the time course of the
response of DAT-KD and wild type mice, respectively, to
saline, 5 mg/kg, 10 mg/kg and 20 mg/kg cocaine. DAT-KD
mice displayed higher basal locomotor activity (p < 0.001,
t-test) than their wild type littermates (Fig. 1C). This
observation is consistent with previously published
results [18]. Fig. 1D shows the total distance traveled in 30
min after injection of saline or different doses of cocaine.
Two way ANOVA detected a main effect of drug (F3,66 =
22.38, p < 0.001) and significant difference between gen-
otypes (F1,66 = 19.57, p < 0.001); but the drug-genotype
interaction did not reach a significant level (F3,66 = 2.686,
p = 0.053). The data were further analyzed with post hoc
Bonferroni tests. Comparing the two genotypes of mice,
we found no difference between WT and DAT-KD mice in
distance traveled after saline injection (p > 0.05), despite
the higher basal locomotor activity in DAT-KD mice.
However, 5 mg/kg and 10 mg/kg cocaine had a greater
stimulating effect on locomotor activity in the DAT-KD
mice (p < 0.01 and p < 0.001), while there was no signif-
icant difference in the effects of 20 mg/kg cocaine on the
two genotypes of mice (p > 0.05). For the cocaine effect,
post hoc tests indicated that 5, 10, and 20 mg/kg cocaine
significantly stimulated locomotor activity compared to
saline in the DAT-KD mice (p < 0.01, p < 0.001, and p <
0.001). In the wild type mice, 5 mg/kg cocaine did not sig-
nificantly stimulate locomotor activity, while 10 and 20
mg/kg cocaine did (p > 0.05, p < 0.001, and p < 0.001
respectively).Page 2 of 7
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Next, we tested whether cocaine can still produce reward
in DAT-KD mice using the CPP test. As shown in Fig. 2, 5
mg/kg and 20 mg/kg cocaine significantly increased the
time spent in cocaine-paired chamber by both wild type
and DAT-KD mice. Statistical analysis with ANOVA indi-
cated a main drug effect (F2,40 = 24.25, p < 0.0001), the
lack of a difference between genotypes (F1,40 = 0.1180, p >
0.05) and the lack of a drug-genotype interaction (F2,40 =
0.8827, p > 0.05). Post-hoc Bonferroni analysis showed
the increase in time spent in the cocaine-paired chamber
was significant at 5 mg/kg and 20 mg/kg cocaine for both
wild type (p < 0.05 and 0.01 respectively) and DAT-KD
mice (p < 0.001 and 0.001 respectively). The time mice
spent in the unpaired chamber decreased in the cocaine
treated groups (data not shown). Therefore, the rewarding
effect of cocaine is preserved in DAT-KD mice in which the
activity of DAT, the primary target of cocaine, is dramati-
cally reduced.
Discussion
The dopamine transporter is a key component in the reg-
ulation of DA neurotransmission. Most evidence suggests
that the blockade of DAT and the subsequent increase in
extracellular DA primarily mediate the stimulating and
rewarding effects of cocaine. However, the persistence of
the rewarding effect of cocaine in DAT-KO mice suggests a
mechanism of DAT-independent cocaine reward, which
might be due to the extensive adaptive changes in DAT-
KO mice. To test whether the DAT-independent cocaine
reward also plays a role in normal mice, we made a knock-
in mouse line with the endogenous DAT replaced by a
cocaine-resistant DAT mutant. In these DAT-CI mice,
cocaine suppresses locomotion and does not produce
reward, supporting the hypothesis that cocaine blockade
of DAT is required for cocaine reward in normal mice
[17]. However, DAT activity in DAT-CI mice is signifi-
Cocaine induced CPP in DAT-KD mutant mice and WT miceFigure 2
Cocaine induced CPP in DAT-KD mutant mice and 
WT mice. CPP is represented by the difference in the time 
mice spend in the drug-paired chamber between pre-condi-
tioning day and post-conditioning day. Both 5 and 20 mg/kg 
cocaine produced significant CPP in both WT mice and 
DAT-KD mice (for drug effect, F2,1 = 24.25, p < 0.0001). 
Eight mice were examined in each group. Error bars repre-
sent standard error of means. Post hoc Bonferroni tests ver-
sus saline: *, p < 0.05; **, p < 0.01; ***, p < 0.001.
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Effect of cocaine on locomotor activity in DAT-KD 
mutant mice compared to WT mice. Mice were habitu-
ated to the locomotor test chamber for 60 minutes. Cocaine 
or saline were injected (ip) and mice were returned to the 
test chamber and monitored for another 60 min. A) and B): 
Time course of locomotor activity of WT mice and DAT-KD 
mice. Saline, 5 mg/kg, 10 mg/kg or 20 mg/kg cocaine was 
given at the time indicated by the arrows. Data shown are 
average distance traveled in 5 min. C) Total distance traveled 
in 60 minutes for wild type and DAT-KD mice during their 
habituation to the chambers before drug or saline injection. 
DAT-KD mice are significantly more active than wild type ice 
(***, p < 0.001, t-test). D) Total distance traveled in 30 min 
after the injection of saline or 5, 10, or 20 mg/kg cocaine with 
6 – 8 mice in each group. Two-way ANOVA was performed. 
Cocaine significantly increased locomotor activities in both 
genotypes of mice (for drug effect, F3,66 = 22.38, p < 0.001) 
and had greater effect on DAT-KD mice than on the WT 
mice (for genotype, F1,66 = 19.57, p < 0.001). Error bars rep-
resent standard error of means. Post hoc Bonferroni tests 
versus saline: *, p < 0.05; **, p < 0.01; ***, p < 0.001. Com-
paring between the two genotypes, 5 mg/kg and 10 mg/kg 
cocaine had a greater effect on locomotor activity in the 
DAT-KD mice than in wild type mice (#, p < 0.01).
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DAT have been shown to alter behaviors or drug
responses. For example, reduced DAT activity in DAT-KD
mice has been shown to alter behavioral responses to
amphetamine, another psychostimulant that impacts the
dopaminergic system [18]. It remains a concern that in
DAT-CI mice the lack of cocaine response might be due to
compensatory changes from the lowered DAT activity.
Therefore, we studied cocaine effects on DAT-KD mice.
The DAT-KO and DAT-CI mice were generated using ES
cells from 129Sv/J mice and crossed with C57BL6 mice,
thus they have a mixed genetic background [17]. Several
studies used mice that were backcrossed with C57BL6
mice for many generations [17]. The original DAT-KD
mice were generated in 129Sv/J background but this strain
does not respond well in many tests that are used to eval-
uate psychostimulant effects. Therefore, the DAT-KD mice
used in this study were backcrossed to C57BL/6J for 8 to 9
generations and thus their background matches with the
backgrounds of both the DAT-CI mice and DAT-KO mice.
This is important because it has been shown that cocaine's
effects are not the same in different strains of mice
[21,22]. In addition, DAT-KO mice backcrossed to differ-
ent strain backgrounds also respond to cocaine differently
[23].
In DAT-KD mice, DAT activity is reduced to 10% of the
wild type level, resulting in a hyperdopaminergic tone and
increased locomotor activity [18]. In addition, DAT-KD
mice have an altered response to amphetamine, which
might be due to an altered balance between DA autorecep-
tor and heteroreceptor functions [18]. Amphetamine ele-
vates extracellular DA by interacting with DAT and, more
importantly, with the vesicular monoamine transporter,
inhibiting DA uptake, and inducing DA release from DA
containing vesicles to the cytosol through the vesicular
monoamine transporter and to the extracellular space
through DAT [5]. In contrast, cocaine elevates extracellu-
lar DA by simply binding to DAT and inhibiting DA
reuptake. Despite the vastly different mechanisms of
action, amphetamine and cocaine both increase DA in the
synapse and enhance dopaminergic neurotransmission,
thereby stimulating locomotor activity and producing
reward in animals. The fact that amphetamine produces
locomotor inhibition instead of stimulation in DAT-KD
mice suggested the possibility that cocaine effects might
also be altered in these mice.
Fig. 1 shows that DAT-KD mice had considerably higher
baseline locomotor activity than WT mice before drug or
saline injection and this difference was statistically signif-
icant (Fig. 1C). This result confirms our previous observa-
tion [18] and is consistent with the hyperdopaminergic
tone in these mice [18]. Fig. 1 also shows that cocaine
clearly increased locomotor activity in DAT-KD mice as
well as in WT mice. While cocaine was capable of increas-
ing locomotor activity in both genotypes, there were dif-
ferences in each genotype's response. For instance, both 5
and 10 mg/kg cocaine produced stronger locomotor stim-
ulation in DAT-KD mice than it did in wild type mice (Fig.
1D). The reason for this difference is not clear but could
be due to presynaptic or postsynaptic adaptive changes,
such as reduced D2 autoreceptor signaling, in response to
the hyperdopaminergic tone in DAT-KD mice. It is also
not clear why the amphetamine effect is altered in DAT-
KD mice while the cocaine effect is maintained. Our
results demonstrate that a dramatically reduced DAT
activity does not lead to a loss or a reduction of the stim-
ulating effect of cocaine. This is in contrast to observations
of DAT-KO mice and DAT-CI mice. In heterozygous DAT-
KO mice, DAT activity is reduced by 50% and cocaine
stimulates locomotion as well as in WT mice; while in
homozygous DAT-KO mice, DAT is absent and cocaine
has no effect on locomotion [24]. In DAT-CI mice, the
mutated DAT is over 50-fold less sensitive to cocaine inhi-
bition but has lower uptake activity. Instead of stimula-
tion, cocaine suppresses locomotor activity in DAT-CI
mice [17]. The fact that cocaine retains these effects in
both heterozygous DAT-KO mice and DAT-KD mice indi-
cates that the reduction of DAT expression and thus DAT
activity to 50% and 10% of wild type mice does not by
itself lead to adaptive changes that abolish the stimulating
effect of cocaine and in fact, 10% DAT activity seems to be
sufficient for the preservation of many normal functions,
such as some cocaine responses. Therefore, the locomotor
suppression observed in DAT-CI mice is not due to
reduced DA clearance or changes in DA homeostasis but
is due to the lack of cocaine inhibition of DAT and to
cocaine effects on other cocaine targets. Cocaine inhibi-
tion of DAT, SERT, and NET and the resulting enhance-
ment of neurotransmission in all three systems may
contribute to the locomotor effect in wild type mice.
Cocaine inhibition of SERT and/or NET in the absence of
DAT inhibition in DAT-CI mice leads to locomotor sup-
pression. It is not clear whether cocaine inhibition of
SERT or NET enhances or dampens locomotor stimula-
tion in wild type mice where DAT is also inhibited. Fur-
ther studies are being performed to assess the role of SERT
and NET in locomotor suppression.
Cocaine and other addictive drugs are known to produce
reward in humans as well as in mice and other animals.
CPP tests are commonly used to measure the rewarding
properties of drugs. In this behavioral test, drug adminis-
tration to animals is repeatedly paired with a set of envi-
ronmental cues. When allowed to explore freely, the
animals spend more time in the environment paired with
a drug that produces reward.Page 4 of 7
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not enough to inhibit the cocaine-insensitive mutant DAT
and elevate extracellular DA in DAT-CI mice [17]. We have
also shown that cocaine lost its ability to produce reward
in DAT-CI mice while amphetamine still produces CPP in
these mice. Therefore, we conclude that the reward path-
way in DAT-CI mice is functional and the lack of cocaine-
induced reward in DAT-CI mice is due to the inability of
cocaine to block the modified DAT. However, DAT activ-
ity in DAT-CI mice is significantly lower than that in WT
mice. The DA clearance rate in DAT-CI mice is between
those of DAT-KD mice and heterozygous DAT-KO mice
[17]. It remains a concern that lowered DAT activity might
lead to neuroadaptations that may alter cocaine effects.
Thus, we examined whether cocaine is still able to pro-
duce reward in DAT-KD mice that have only 10% of wild
type DAT expression. Fig. 2 shows that cocaine still pro-
duced robust CPP in DAT-KD mice. In addition, cocaine
produces reward in heterozygous DAT-KO mice [9-11].
These results demonstrate that the reduction of DAT activ-
ity and elevated dopaminergic tone does not abolish
cocaine's rewarding effect in mice.
Several mouse models have been generated with altera-
tions to the DAT gene, providing excellent tools to study
the functions of DAT and the mechanism of cocaine
effects: DAT-KD mice [18] and heterozygous DAT-KO
mice [24] with DAT expression reduced to 10% and 50%
of the wild type level respectively, DAT-CI mice [17] with
a cocaine-insensitive DAT mutant that is functional but
with reduced uptake activity, and homozygous DAT-KO
mice [24] with DAT completely deleted. Heterozygous
DAT-KO mice [24]and DAT-KD mice have significantly
elevated DA tone but in these mice DAT is blocked by
cocaine and the mice respond to cocaine similarly to wild
type mice. The adaptive changes to the elevated dopamin-
ergic tone in these mice are likely to be moderate. The
changes do not abolish cocaine's ability to produce
reward or to stimulate locomotor activity. Therefore, it is
likely that the mechanism of cocaine action in these mice
is similar to that in wild type mice.
In DAT-CI mice, DA uptake activity is reduced and the
basal DA tone is also significantly elevated [17]. Since the
extent of basal DA elevation in DAT-CI mice is between
those in heterozygous DAT-KO and DAT-KD mice [17], it
is reasonable to assume that the adaptive changes in DAT-
CI mice are also moderate and do not interrupt the drug
reward pathway. We have shown that amphetamine still
produces reward in DAT-CI mice suggesting a functional
reward pathway [17]. Although the elevated basal DA
tone is due to reduced DAT activity in all mouse lines, the
causes of the reduction are different; reduced expression
of wild type DAT, in heterozygous DAT-KO and DAT-KD
mice, versus normal expression of a mutant DAT with
lower uptake activity in DAT-CI mice. Therefore, it is still
possible that the mutated DAT in DAT-CI mice may cause
unique adaptive changes, by an unknown mechanism,
which could abolish cocaine reward and locomotor stim-
ulation.
In contrast, in homozygous DAT-KO mice DAT is com-
pletely lacking. Intriguingly, the elimination of DAT, the
consequent severe alteration of DA homeostasis and
related pathways, and the tremendous adaptive changes
still fail to abolish the rewarding effect of cocaine [24].
However, the mechanism of cocaine reward in DAT-KO
mice is very different from that in wild type mice. For
example, inhibition of SERT or NET with selective inhibi-
tors elevates DA levels in the nucleus accumbens and pro-
duces reward in DAT-KO mice but not in wild type mice
[24]. These results indicate that the complete deletion of
DAT significantly alters the mechanism of cocaine effects.
It seems that cocaine-induced DA elevation in the nucleus
accumbens is still critical and the signaling from serot-
oninergic or noradrenergic systems to the dopaminergic
system might be altered. The exact mechanism is not clear
and currently under intensive investigation.
Conclusion
In summary, genetically modified mouse strains with a
reduction in DAT function by 50% (heterozygous DAT-
KO mice) and 90% (DAT-KD mice) retain the stimulating
and rewarding effects of cocaine. These results are consist-
ent with the idea that reduced DAT activity in DAT-CI
mice does not lead to adaptive changes that abolish the
stimulating and rewarding effects of cocaine. Therefore,
the lack of cocaine reward and locomotor stimulation in
DAT-CI mice is unlikely due to reduced DAT activity or
the resulting hyperdopaminergic tone, but due to the ina-
bility of cocaine to inhibit the modified DAT. This inves-
tigation lends further support to the conclusion that
cocaine inhibition of DAT is necessary for the rewarding
and stimulating effects of cocaine.
Methods
Animals
The DAT-KD mice were generated by the insertion of a
DNA construct containing the neomycin-resistant gene
and other elements into the promoter region of DAT gene
in an attempt to control DAT expression [18]. This pro-
moter modification results in a 90% reduction in DAT
expression [18]. Mice used in this study were produced
from the breeders that have been backcrossed with
C57BL/6J mice for 8–9 generations. Heterozygous male
and female DAT-KD mice were bred to produce
homozygous DAT-KD mice and their WT littermates used
in the experiments. The genotypes of the mice used in
these experiments were determined by PCR using forward
primer TGGGGTCCACATACAAATGATGA and reversePage 5 of 7
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between 10 and 14 weeks of age were used in this study.
Mice were group housed, with 3 – 5 mice per cage, on a 12
hour day/night cycle with lights off at 6 pm. Food and
water was provided ad libitum. All procedures were con-
ducted in accordance with the animal use committee at
The Ohio State University. Experiments were performed
between 9:00 am and 5:00 pm. Only drug naïve animals
were used in experiments and separate animals were used
for the locomotor and CPP studies.
Drugs
The drug supply program of National Institute on Drug
Abuse, NIH (Bethesda, MD), kindly supplied cocaine
HCL. Doses of 5 mg/kg, 10 mg/kg and 20 mg/kg were
given for the locomotion studies and doses of 5 mg/kg
and 20 mg/kg were used for the CPP studies. Vehicle
(0.9% NaCl) and cocaine were administered through
intraperitoneal (i.p.) injection.
Locomotion tests
Locomotion tests were performed in acrylic test chambers
measuring 25 cm(W) × 25 cm(L) × 25 cm(H) that are
inside a sound-attenuating behavioral test enclosure. Mice
were placed in the chamber without drugs for 60 min. The
total distance traveled during this time was used to deter-
mine the basal activity. Then cocaine or vehicle was
administered and mouse locomotor activities were moni-
tored for another 60 minutes. Cumulative distance
traveled and speed was recorded by a video-based moni-
toring system, Limelight (Actimetrics, Evanston, IL). The
stimulatory effects of cocaine peaked between 10 and 20
minutes, thus we used distance traveled within the first 30
minutes after injection as a measurement of cocaine effect
on locomotion.
Conditioned place preference
CPP was performed as previously described [17]. In this
setup, we used a three-chambered box with the two end
chambers differing in wall patterns and floor materials.
One chamber had a thin wavy pattern on a white back-
ground on the walls and thin-mesh flooring, while the
other chamber had a thick grid pattern on a white back-
ground on the walls and thick-mesh flooring. The middle
chamber, used as a neutral initial placement point, had
gray walls and a slick, acrylic floor. On the pre-condition-
ing day (day 1) mice were locked in the middle chamber
for 30 seconds, then allowed to freely explore the entire
apparatus for 30 min. Movement and time spent in each
chamber was recorded with the video-based monitoring
system LimeLight. Mice did not show a significant prefer-
ence for either end chamber. Mice were randomly paired
to one end chamber and randomly divided into saline
control and cocaine-injected groups. On days 2, 4, 6, and
8, the mice were injected with saline and confined in one
of the two end chambers for 30 min; and on days 3, 5, 7,
and 9, the mice were injected with cocaine or saline and
confined to the opposite end chamber for 30 minutes. On
the test day (day 10), the mice were confined to the central
chamber for 30 seconds, and then allowed free access to
both end chambers for 30 min. The time spent in each of
the end chambers was recorded. The difference between
the time spent in the paired chamber on pre-conditioning
day and time spent in the same chamber on post-condi-
tioning day was calculated and presented.
Data analysis
The experimental data were analyzed by two-way ANOVA
and post hoc Bonferroni tests using GraphPad Prism
(GraphPad Software, Inc. San Diego, CA)
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